Arkolith/Insider Trading/FHTX/Form 4

Gottschalk Adrian

Chief Executive Officer, DirectorFoghorn Therapeutics Inc. (FHTX) · full profile →Form 4 · filed Feb 6, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
0 non-derivative · 1 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 5, 2026Grant(A)1.1M$5.23$5.6M1.1M

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001828724-26-000003) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML